We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Quarterly updates to the emergency presentations of cancer data by Public Health England.
You may need to tell DVLA if you have cancer - if you do, download the correct form to let them know
You may need to tell DVLA if you have lung cancer - download the correct form if you need to let them know
This national report provides insights into the care experienced by cancer patients across England who were treated as day cases or inpatients during the first three months of 2010.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Government bringing together experts in the field to drive forward progress in tackling cancer in children and young people.
These guidelines give commissioners, providers and healthcare professionals in cancer screening information on consent to screening and procedures.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Guidance on the role of breast screening and symptomatic services in identifying interval cancer and giving results to patients.
How the National Cancer Registration and Analysis Service (NCRAS) will improve awareness of the national cancer registry.
Guidance for delivery partners and contractors.
This call for evidence will inform the development of the government’s 10-year Cancer Plan for England.
Estimated proportion of all malignant cancers where patients first presented as an emergency.
Information on the waiting times of people referred with suspected cancer or breast symptoms and subsequently told the outcome of their diagnosis, and treated for cancer by the NHS in England.
Information on the waiting times of patients with suspected cancer and those subsequently diagnosed with cancer. Information on the number of people who attended outpatient appointments within two weeks of an urgent referral by their GP for suspected cancer or...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.